Preventing acute rejection with basiliximab and triple immunosuppression after renal transplantation

By Kandus A.  

Transplantation Proceedings, Vol. 34, Iss. 7, 2002-11 ,pp. : 2907-2909

Elsevier

Access to resources Recommend Favorite

Safety and efficacy of basiliximab for the prevention of acute rejection in kidney transplant recipients

By Shah M.H.   Bokhari M.Z.M.   Bokhari M.T.M.   Farooq A.   Yousaf S.M.  

Transplantation Proceedings, Vol. 35, Iss. 7, 2003-11 ,pp. : 2737-2738

Elsevier

Access to resources Recommend Favorite

Low rate of acute rejection and cytomegalovirus infection in kidney transplant recipients with basiliximab

By Folkmane I.   Bicans J.   Amerika D.   Chapenko S.   Murovska M.   Rosentals R.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3209-3210

Elsevier

Access to resources Recommend Favorite

Triple immunosuppression with or without basiliximab in pediatric renal transplantation: acute rejection rates at one year

By Duzova A.   Buyan N.   Bakkaloglu M.   Dalgic A.   Soylemezoglu O.   Besbas N.   Bakkaloglu A.  

Transplantation Proceedings, Vol. 35, Iss. 8, 2003-12 ,pp. : 2878-2880

Elsevier

Access to resources Recommend Favorite

Simulect (basiliximab) reduces acute cellular rejection in renal allografts from cadaveric and living donors

By Mulloy L.L.   Wright F.   Hall M.L.   Moore M.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 1210-1213

Elsevier

Access to resources Recommend Favorite